{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T11:50:26Z","timestamp":1768909826130,"version":"3.49.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,2,9]],"date-time":"2013-02-09T00:00:00Z","timestamp":1360368000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s40263-013-0041-6","type":"journal-article","created":{"date-parts":[[2013,2,9]],"date-time":"2013-02-09T02:03:32Z","timestamp":1360375412000},"page":"175-184","source":"Crossref","is-referenced-by-count":64,"title":["Treatment of Epileptic Encephalopathies"],"prefix":"10.1007","volume":"27","author":[{"given":"Amy","family":"McTague","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Helen","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,9]]},"reference":[{"issue":"4","key":"41_CR1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","volume":"51","author":"AT Berg","year":"2010","unstructured":"Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009. Epilepsia. 2010;51(4):676\u201385.","journal-title":"Epilepsia"},{"issue":"3","key":"41_CR2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nrneurol.2012.12","volume":"8","author":"R Nabbout","year":"2011","unstructured":"Nabbout R, Dulac O. Epilepsy: genetics of early-onset epilepsy with encephalopathy. Nat Rev Neurol. 2011;8(3):129\u201330.","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"41_CR3","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1528-1167.2011.03127.x","volume":"52","author":"FJ O\u2019Callaghan","year":"2011","unstructured":"O\u2019Callaghan FJ, Lux AL, Johnson AL, et al. The effect of lead time to treatment and of age of onset on developmental outcome at 4\u00a0years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study. Epilepsia. 2011;52(7):1359\u201364.","journal-title":"Epilepsia"},{"issue":"12","key":"41_CR4","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/j.1528-1167.2006.00888.x","volume":"47","author":"ZR Primec","year":"2006","unstructured":"Primec ZR, Stare J, Neubauer D. The risk of lower mental outcome in infantile spasms increases after three weeks of hypsarrhythmia duration. Epilepsia. 2006;47(12):2202\u20135.","journal-title":"Epilepsia"},{"issue":"3","key":"41_CR5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.0013-9580.2004.30503.x","volume":"45","author":"S Kivity","year":"2004","unstructured":"Kivity S, Lerman P, Shinnar S, et al. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia. 2004;45(3):255\u201362.","journal-title":"Epilepsia"},{"issue":"2","key":"41_CR6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/01.wnl.0000168908.78118.99","volume":"65","author":"S Goh","year":"2005","unstructured":"Goh S, Kwiatkowski DJ, Thiele EA, et al. Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex. Neurology. 2005;65(2):235\u20138.","journal-title":"Neurology"},{"key":"41_CR7","first-page":"270","volume":"8","author":"S Ohtahara","year":"1976","unstructured":"Ohtahara S, Ishida T, Oka E. On the specific age dependent epileptic syndrome: the early-infantile epileptic encephalopathy with suppression-burst. No to Hattatsu. 1976;8:270\u20139.","journal-title":"No to Hattatsu"},{"issue":"1","key":"41_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0387-7604(01)00392-8","volume":"24","author":"Y Yamatogi","year":"2002","unstructured":"Yamatogi Y, Ohtahara S. Early-infantile epileptic encephalopathy with suppression-bursts, Ohtahara syndrome; its overview referring to our 16 cases. Brain Dev. 2002;24(1):13\u201323.","journal-title":"Brain Dev"},{"issue":"6","key":"41_CR9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/ng.150","volume":"40","author":"H Saitsu","year":"2008","unstructured":"Saitsu H, Kato M, Tohyama J, et al. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet. 2008;40(6):782\u20138.","journal-title":"Nat Genet"},{"issue":"2","key":"41_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/518903","volume":"81","author":"M Kato","year":"2007","unstructured":"Kato M, Saitoh S, Akasaka M, et al. A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara syndrome). Am J Hum Genet. 2007;81(2):361\u20136.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"41_CR11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1399-0004.2009.01236.x","volume":"76","author":"F Molinari","year":"2009","unstructured":"Molinari F, Kaminska A, Plouin P, et al. Mutations in the mitochondrial glutamate carrier SLC25A22 in neonatal epileptic encephalopathy with suppression bursts. Clin Genet. 2009;76(2):188\u201394.","journal-title":"Clin Genet"},{"issue":"2","key":"41_CR12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1086\/427564","volume":"76","author":"F Molinari","year":"2005","unstructured":"Molinari F, Raas-Rothschild A, Palmieri L, et al. Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am J Hum Genet. 2005;76(2):334\u20139.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"41_CR13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1212\/WNL.0b013e318227046d","volume":"77","author":"D Carranza Rojo","year":"2011","unstructured":"Carranza Rojo D, Hamiwka L, Suls A, et al. De novo SCN1A mutations in migrating partial seizures of infancy. Neurology. 2011;77(4):380\u20133.","journal-title":"Neurology"},{"issue":"8","key":"41_CR14","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1111\/j.1528-1167.2012.03538.x","volume":"53","author":"A Poduri","year":"2012","unstructured":"Poduri A, Chopra SS, Meyer E, et al. Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy. Epilepsia. 2012;53(8):e146\u201350.","journal-title":"Epilepsia"},{"key":"41_CR15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1528-1167.2011.03226.x","volume":"52","author":"A Poduri","year":"2011","unstructured":"Poduri A, Heinzen EL, Walsh CA, et al. Whole exome sequencing implicates SLC25A22 as a gene for MMPEI [abstract]. Epilepsia. 2011;52:16.","journal-title":"Epilepsia"},{"issue":"11","key":"41_CR16","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ng.2441","volume":"44","author":"G Barcia","year":"2012","unstructured":"Barcia G, Fleming MR, Nabbout R, et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet. 2012;44(11):1255\u20139.","journal-title":"Nat Genet"},{"key":"41_CR17","doi-asserted-by":"crossref","unstructured":"McTague A, Appleton R, Avula S, et al. Migrating partial seizures of infancy (MPSI): expansion of the electroclinical, radiological and pathological disease spectrum. Brain. 2013 (in press)","DOI":"10.1093\/brain\/awt073"},{"issue":"5","key":"41_CR18","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/01.wnl.0000266594.16202.c1","volume":"69","author":"R Guerrini","year":"2007","unstructured":"Guerrini R, Moro F, McShane MA, et al. Expansion of the first PolyA tract of ARX causes infantile spasms and status dystonicus. Neurology. 2007;69(5):427\u201333.","journal-title":"Neurology"},{"issue":"9","key":"41_CR19","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/jmg.2006.041467","volume":"43","author":"HL Archer","year":"2006","unstructured":"Archer HL, Evans J, Osborne J, et al. CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. J Med Genet. 2006;43(9):729\u201334.","journal-title":"J Med Genet"},{"issue":"7","key":"41_CR20","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1528-1167.2010.02534.x","volume":"51","author":"S Auvin","year":"2010","unstructured":"Auvin S, Lamblin MD, Bouvet-Mourcia A, et al. Infantile epileptic encephalopathy with late-onset spasms: report of 19 patients. Epilepsia. 2010;51(7):1290\u20136.","journal-title":"Epilepsia"},{"issue":"6","key":"41_CR21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/320609","volume":"68","author":"L Claes","year":"2001","unstructured":"Claes L, Del-Favero J, Ceulemans B, et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet. 2001;68(6):1327\u201332.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"41_CR22","doi-asserted-by":"crossref","first-page":"e1000381","DOI":"10.1371\/journal.pgen.1000381","volume":"5","author":"C Depienne","year":"2009","unstructured":"Depienne C, Bouteiller D, Poirier K, et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet. 2009;5(2):e1000381.","journal-title":"PLoS Genet"},{"issue":"1","key":"41_CR23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1474-4422(08)70292-8","volume":"8","author":"A Arzimanoglou","year":"2009","unstructured":"Arzimanoglou A, French J, Blume WT, et al. Lennox\u2013Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol. 2009;8(1):82\u201393.","journal-title":"Lancet Neurol"},{"issue":"Suppl. 1","key":"41_CR24","first-page":"S3","volume":"13","author":"A Arzimanoglou","year":"2011","unstructured":"Arzimanoglou A, Resnick T. All children who experience epileptic falls do not necessarily have Lennox\u2013Gastaut syndrome \u2026 but many do. Epilept Disord. 2011;13(Suppl. 1):S3\u201313.","journal-title":"Epilept Disord"},{"issue":"2","key":"41_CR25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.yebeh.2010.10.015","volume":"20","author":"JR Hughes","year":"2011","unstructured":"Hughes JR. A review of the relationships between Landau\u2013Kleffner syndrome, electrical status epilepticus during sleep, and continuous spike-waves during sleep. Epilepsy Behav. 2011;20(2):247\u201353.","journal-title":"Epilepsy Behav"},{"issue":"1\u20132","key":"41_CR26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.eplepsyres.2011.07.021","volume":"97","author":"M Trivisano","year":"2011","unstructured":"Trivisano M, Specchio N, Cappelletti S, et al. Myoclonic astatic epilepsy: an age-dependent epileptic syndrome with favorable seizure outcome but variable cognitive evolution. Epilepsy Res. 2011;97(1\u20132):133\u201341.","journal-title":"Epilepsy Res"},{"issue":"11","key":"41_CR27","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1469-8749.2010.03744.x","volume":"52","author":"S Kelley","year":"2010","unstructured":"Kelley S, Kossoff E. Doose syndrome (myoclonic-astatic epilepsy): 40\u00a0years of progress. Dev Med Child Neurol. 2010;52(11):988\u201393.","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"41_CR28","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/j.1528-1167.2011.03250.x","volume":"52","author":"U Kramer","year":"2011","unstructured":"Kramer U, Chi CS, van Baalen A, et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia. 2011;52(11):1956\u201365.","journal-title":"Epilepsia"},{"issue":"1","key":"41_CR29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1528-1167.2011.03350.x","volume":"53","author":"KB Howell","year":"2012","unstructured":"Howell KB, Katanyuwong K, Mackay MT, et al. Long-term follow-up of febrile infection-related epilepsy syndrome. Epilepsia. 2012;53(1):101\u201310.","journal-title":"Epilepsia"},{"issue":"3","key":"41_CR30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/brain\/awp336","volume":"133","author":"WG Leen","year":"2010","unstructured":"Leen WG, Klepper J, Verbeek MM, et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain. 2010;133(3):655\u201370.","journal-title":"Brain"},{"issue":"1\u20132","key":"41_CR31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymgme.2011.05.014","volume":"104","author":"S Stockler","year":"2011","unstructured":"Stockler S, Plecko B, van Karnebeek C, et al. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up. Mol Genet Metab. 2011;104(1\u20132):48\u201360.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"41_CR32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10545-006-0508-4","volume":"30","author":"GF Hoffmann","year":"2007","unstructured":"Hoffmann GF, Schmitt B, Bagci S, et al. Pyridoxal 5\u2032-phosphate may be curative in early-onset epileptic encephalopathy. J Inherit Metab Dis. 2007;30(1):96\u20139.","journal-title":"J Inherit Metab Dis"},{"key":"41_CR33","unstructured":"National Institute for Clinical Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care [online]. Available from URL: http:\/\/www.nice.org.uk\/cg137 [Accessed 2013 Jan 23]."},{"issue":"12","key":"41_CR34","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1111\/j.1528-1167.2010.02772.x","volume":"51","author":"M Maguire","year":"2010","unstructured":"Maguire M, Hemming K, Marson AG, et al. Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review. Epilepsia. 2010;51(12):2423\u201331.","journal-title":"Epilepsia"},{"issue":"11","key":"41_CR35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/11317650-000000000-00000","volume":"23","author":"JM Wild","year":"2009","unstructured":"Wild JM, Chiron C, Perucca E, et al. Visual field loss in patients with refractory partial epilepsy treated with vigabatrin. CNS Drugs. 2009;23(11):965\u201382.","journal-title":"CNS Drugs"},{"issue":"2","key":"41_CR36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1528-1167.2008.01961.x","volume":"50","author":"E Gaily","year":"2009","unstructured":"Gaily E, Jonsson H, Lappi M. Visual fields at school-age in children treated with vigabatrin in infancy. Epilepsia. 2009;50(2):206\u201316.","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"41_CR37","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1177\/088307380001500104","volume":"15","author":"TA Glauser","year":"2000","unstructured":"Glauser TA. Topiramate in the catastrophic epilepsies of childhood. J Child Neurol. 2000;15(Suppl. 1):S14\u201321.","journal-title":"J Child Neurol"},{"issue":"1","key":"41_CR38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0920-1211(02)00010-4","volume":"49","author":"G Coppola","year":"2002","unstructured":"Coppola G, Capovilla G, Pascotto A, et al. Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial. Epilepsy Res. 2002;49(1):45\u20138.","journal-title":"Epilepsy Res"},{"issue":"9242","key":"41_CR39","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","volume":"356","author":"C Chiron","year":"2000","unstructured":"Chiron C, Marchand MC, Vincent J, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet. 2000;356(9242):1638\u201342.","journal-title":"Lancet"},{"issue":"21","key":"41_CR40","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1212\/01.wnl.0000303813.95800.0d","volume":"70","author":"T Glauser","year":"2008","unstructured":"Glauser T, Kluger G, Arroyo S, et al. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology. 2008;70(21):1950\u20138.","journal-title":"Neurology"},{"issue":"5","key":"41_CR41","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ejpn.2011.12.012","volume":"16","author":"C Stulpnagel von","year":"2012","unstructured":"von Stulpnagel C, Coppola G, Kluger G, et al. First long-term experience with the orphan drug rufinamide in children with myoclonic-astatic epilepsy (Doose syndrome). Eur J Paediatr Neurol. 2012;16(5):459\u201363.","journal-title":"Eur J Paediatr Neurol"},{"issue":"7","key":"41_CR42","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1528-1167.2012.03458.x","volume":"53","author":"N Fejerman","year":"2012","unstructured":"Fejerman N, Caraballo R, Amartino H, et al. Sulthiame add-on therapy in children with focal epilepsies associated with encephalopathy related to electrical status epilepticus during slow sleep (ESES). Epilepsia. 2012;53(7):1156\u201361.","journal-title":"Epilepsia"},{"issue":"6","key":"41_CR43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.pediatrneurol.2010.02.013","volume":"42","author":"ML Zupanc","year":"2010","unstructured":"Zupanc ML, Roell Werner R, Hecox KE, et al. Efficacy of felbamate in the treatment of intractable pediatric epilepsy. Pediatr Neurol. 2010;42(6):396\u2013403.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"41_CR44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0387-7604(99)00108-4","volume":"22","author":"K Okuda","year":"2000","unstructured":"Okuda K, Yasuhara A, Kobayashi Y, et al. Successful control with bromide of two patients with malignant migrating partial seizures in infancy. Brain Dev. 2000;22(1):56\u20139.","journal-title":"Brain Dev"},{"issue":"1","key":"41_CR45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0032-1307454","volume":"43","author":"J Lotte","year":"2012","unstructured":"Lotte J, Haberlandt E, Kluger GJ, et al. Bromide in patients with SCN1A-mutations manifesting as Dravet syndrome. Neuropediatrics. 2012;43(1):17\u201321.","journal-title":"Neuropediatrics"},{"issue":"6","key":"41_CR46","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.seizure.2005.07.002","volume":"14","author":"H Verhelst","year":"2005","unstructured":"Verhelst H, Boon P, Meirleir LD, et al. Steroids in intractable childhood epilepsy: clinical experience and review of the literature. Seizure. 2005;14(6):412\u201321.","journal-title":"Seizure"},{"key":"41_CR47","doi-asserted-by":"crossref","unstructured":"Gayatri NA, Ferrie CD, Cross H. Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms. Cochrane Database Syst Rev. 2007;24(1):CD005222.","DOI":"10.1002\/14651858.CD005222.pub2"},{"issue":"11","key":"41_CR48","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1474-4422(05)70199-X","volume":"4","author":"AL Lux","year":"2005","unstructured":"Lux AL, Edwards SW, Newton RW, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14\u00a0months: a multicentre randomised trial. Lancet Neurol. 2005;4(11):712\u20137.","journal-title":"Lancet Neurol"},{"issue":"1","key":"41_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1684\/epd.2012.0482","volume":"14","author":"P Veggiotti","year":"2012","unstructured":"Veggiotti P, Pera MC, Tassinari CA, et al. Therapy of encephalopathy with status epilepticus during sleep (ESES\/CSWS syndrome): an update. Epilept Disord. 2012;14(1):1\u201311.","journal-title":"Epilept Disord"},{"issue":"7","key":"41_CR50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1528-1167.2009.02224.x","volume":"50","author":"M Buzatu","year":"2009","unstructured":"Buzatu M, Bulteau C, Van Bogaert P, et al. Corticosteroids as treatment of epileptic syndromes with continuous spike-waves during slow-wave sleep. Epilepsia. 2009;50(7):68\u201372.","journal-title":"Epilepsia"},{"issue":"6","key":"41_CR51","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1474-4422(08)70092-9","volume":"7","author":"EG Neal","year":"2008","unstructured":"Neal EG, Chaffe H, Fitzsimmons G, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7(6):500\u20136.","journal-title":"Lancet Neurol"},{"issue":"2","key":"41_CR52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1684\/j.1950-6945.2006.tb00174.x","volume":"8","author":"RH Caraballo","year":"2006","unstructured":"Caraballo RH, Cersosimo RO, Fejerman N, et al. Ketogenic diet in patients with myoclonic-astatic epilepsy. Epilept Disord. 2006;8(2):151\u20135.","journal-title":"Epilept Disord"},{"issue":"3","key":"41_CR53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5698\/1535-7511-11.3.88","volume":"11","author":"E Kossoff","year":"2011","unstructured":"Kossoff E. The fat is in the fire: ketogenic diet for refractory status epilepticus. Epilepsy Curr. 2011;11(3):88\u20139.","journal-title":"Epilepsy Curr"},{"issue":"5","key":"41_CR54","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1469-8749.2012.04233.x","volume":"54","author":"ME Lemmon","year":"2012","unstructured":"Lemmon ME, Terao NN, Kossoff EH, et al. Efficacy of the ketogenic diet in Lennox\u2013Gastaut syndrome: a retrospective review of one institution\u2019s experience and summary of the literature. Dev Med Child Neurol. 2012;54(5):464\u20138.","journal-title":"Dev Med Child Neurol"},{"issue":"Suppl. 2","key":"41_CR55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1528-1167.2011.03009.x","volume":"52","author":"RH Caraballo","year":"2011","unstructured":"Caraballo RH. Nonpharmacologic treatments of Dravet syndrome: focus on the ketogenic diet. Epilepsia. 2011;52(Suppl. 2):79\u201382.","journal-title":"Epilepsia"},{"issue":"4","key":"41_CR56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1212\/01.wnl.0000266386.55715.3f","volume":"69","author":"E Wyllie","year":"2007","unstructured":"Wyllie E, Lachhwani DK, Worley S, et al. Successful surgery for epilepsy due to early brain lesions despite generalized EEG findings. Neurology. 2007;69(4):389\u201397.","journal-title":"Neurology"},{"issue":"7","key":"41_CR57","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1469-8749.1997.tb07462.x","volume":"39","author":"RF Asarnow","year":"1997","unstructured":"Asarnow RF, LoPresti C, Shields WD, et al. Developmental outcomes in children receiving resection surgery for medically intractable infantile spasms. Dev Med Child Neurol. 1997;39(7):430\u201340.","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"41_CR58","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1528-1167.2010.02783.x","volume":"52","author":"ME Peltola","year":"2011","unstructured":"Peltola ME, Liukkonen E, Valanne L, et al. The effect of surgery in encephalopathy with electrical status epilepticus during sleep. Epilepsia. 2011;52(3):602\u20139.","journal-title":"Epilepsia"},{"issue":"S7","key":"41_CR59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1528-1167.2009.02223.x","volume":"50","author":"JH Cross","year":"2009","unstructured":"Cross JH, Neville BG. The surgical treatment of Landau\u2013Kleffner syndrome. Epilepsia. 2009;50(S7):63\u20137.","journal-title":"Epilepsia."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-013-0041-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-013-0041-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-013-0041-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T19:16:10Z","timestamp":1714936570000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-013-0041-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,9]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1007\/s40263-013-0041-6","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,9]]}}}